• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    • News
      All News Research Reports
    • Reports

    P
    Pharmaceuticals & Biotech.
    SECTOR | 21 Mar 2022

    Pharmaceuticals: Valuations slump as Covid fears ebb; prefer resilient models

    buy
    Pharmaceuticals & Biotech.
    by BOB Capital Markets Ltd.
    BOB Capital Markets Ltd.
    Return of higher operating costs as global economies reopen and rationalisation of growth guidance have undermined pharma valuations
    Copy Link Share on Share on Share on Share on
    Alert  
    Axis Direct released a Sector Update report for Pharmaceuticals & Biotech. on 09 Jul, 2025.
    More from Pharmaceuticals & Biotech.
    Recommended
    Market closes lower, SBI plans a Rs 25,000 crore share sale via a QIP
    Trendlyne Marketwatch | 10 Jul 2025, 04:12PM
    Five winners from analysts: Stocks set to start FY26 with a bang | Screener: Stocks analysts are most …
    The Baseline | 10 Jul 2025, 12:14PM
    Volume-led growth, price stabilization and new US launches boost Indian pharma
    | 25 Mar 2024
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd